News | Industry

News

Manufacturers repay nearly £600m to NHS in first three months of new voluntary pricing scheme

The first repayment of the new scheme was larger than all quarterly payments under VPAS between 2019 and 2022.…

Published: 15 October 2024

News

BGMA recommends longer lead times on NHS medicines contracts to address shortages

The British Generic Manufacturers Association has made several recommendations to reduce overall medicines shortages, of which it says the “vast majority are commonly used generic medicines”.…

Published: 4 October 2024

News

Pharmacy2U blocked from taking over LloydsDirect premises

The application was refused on the basis that the appeals committee “could not be satisfied that there are procedures likely to secure safe and effective provision of essential services”.…

Published: 5 September 2024

News

Nearly one-third of pharmacists have experienced career-limiting discrimination, reveals survey

Exclusive: Of 1,242 UK pharmacists, 368 answered ‘Yes’ when asked ‘Do you believe you have experienced discrimination that has held you back in your career?’…

Published: 2 August 2024

Feature

How AI is transforming drug discovery

Pharmaceutical companies and start-ups are harnessing AI to improve speed and reduce costs at every stage of the drug discovery and development process.…

Published: 3 July 2024

News

UK should be a ‘stronger destination’ for medicine manufacturers, says Wes Streeting

The shadow health secretary said the NHS was not realising “anywhere near the full potential” of partnering with the life sciences industry on clinical trials and adopting and rolling out new treatments.…

Published: 19 June 2024

News

Half of UK adults affected by drug shortages since 2022, finds survey

Respondents to a survey by the British Generic Manufacturers Association reported going without their medication or travelling to other pharmacies to try and source their medicine as a result of shortages.…

Published: 18 June 2024

News

NICE terminates appraisal of medicine for the treatment of persistent cough

Manufacturer Merck Sharpe & Dohme has decided not to supply the National Institute for Health and Care Excellence with evidence on use of gefapixant (Lyfnua).…

Published: 20 May 2024

News

Varenicline planned for return but ‘not before’ end of 2024, says manufacturer

Pfizer has said smoking cessation therapy varenicline will be reintroduced to the UK, after being withdrawn in October 2021.…

Published: 8 May 2024

News

EMA may ask manufacturers to increase production capacity in response to medicines shortages

The European Medicines Agency has published a list of new recommendations to be implemented on a case-by-case basis, depending on vulnerabilities in the supply chain.…

Published: 25 April 2024